NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Array Biopharma (ARRY)

Technical Analysis Report for NASDAQ stock ARRY Array Biopharma. Dated: 05 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ARRY Array Biopharma then click here. or read Experts views on Array Biopharma or Forecast & share price targets of Array Biopharma

Array Biopharma Opened at 8.18 and Closed at: 7.92, which is -3.54% of previous session's close. It moved within a range of 7.82 and 8.18
The session was a Bearish session with an average volume of 4633800, which is 38.02% of previous session's volumes.

Support for tomorrow is 7.69 and resistance for tomorrow is 8.05
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 7.77, 7.61 resistance for tomorrow's hourly charts is 8.13, 8.33

10 Day SMA for Array Biopharma (ARRY) is 7.55 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Array Biopharma (ARRY) is 7.76 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Array Biopharma (ARRY) is 8.37 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 8 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Array Biopharma is 7.05 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Array Biopharma is at 7.76 and 200 DMA is at 7.05, while 50 DMA and 100 DMA are at 8.37 and 8 respectively

Array Biopharma (ARRY) moving average of 20 SMA is at 7.76 and 20 EMA is at 7.79

Array Biopharma (ARRY) moving average of 50 SMA is at 8.37 and 50 EMA is at 8.05

Array Biopharma (ARRY) moving average of 100 SMA is at 8 and 100 EMA is at 7.88

Array Biopharma (ARRY) moving average of 200 SMA is at 7.05 and 200 EMA is at 7.71

Twist Bioscience has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Twist Bioscience, about 14.29% more returns!

Trillium Therapeutics has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Trillium Therapeutics, about 9.92% more returns!

Theravance Biopharma has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Theravance Biopharma, about 33.34% more returns!

Array Biopharma has performed better than Synergetics Usa in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than Riot Blockchain in short term. Holding Array Biopharma could be a better choice for now!

Regenxbio Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Regenxbio Inc, about 24.98% more returns!

Prothena Corporation has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Prothena Corporation, about 12.41% more returns!

Array Biopharma has performed better than Prophase Labs in short term. Holding Array Biopharma could be a better choice for now!

Oramed Pharmaceuticals has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Oramed Pharmaceuticals, about 30.41% more returns!

Ocular Therapeutix has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Ocular Therapeutix, about 23.52% more returns!

Intellia Therapeutics has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Intellia Therapeutics, about 8.74% more returns!

Minerva Neurosciences has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Minerva Neurosciences, about 11.08% more returns!

Lexicon Pharmaceuticals has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Lexicon Pharmaceuticals, about 20.38% more returns!

Fulgent Genetics has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Fulgent Genetics, about 13% more returns!

Guardant Health has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Guardant Health, about 13.06% more returns!

Kala Pharmaceuticals has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Kala Pharmaceuticals, about 34.34% more returns!

Array Biopharma Technical analysis of indicators

Price action analysis of Array Biopharma (ARRY) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Array Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Array Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Array Biopharma in short term but SELL signal is weak.

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Array Biopharma is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 7.47 and Array Biopharma ARRY stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Array Biopharma ARRY stock. Volume based technical analysis of Array Biopharma ARRY stock is negative.

Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock ARRY Array Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And ARRY Experts View which covers a lot of information including buying and selling signals

ARRY future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Array Biopharma or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet